A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.
Cefonicid has been studied across 11 research domains including 😴 Sleep, 🫘 Kidney, ✨ Skin & Hair, 🫁 Respiratory, 🧠 Focus & Attention. The primary research focus is 😴 Sleep with 18% of studies addressing this area.
This evidence profile for Cefonicid is generated deterministically from 234 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.